Rady Childrens Hospital - San Diego
- Type
- Teaching hospital
- Where
- San Diego, CA
- Medicare CCN
- 053303
- Received
- $280,501 in 68 records, 2022 ($50,527 general, $229,974 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: RADY CHILDRENS HOSPITAL SAN DIEGO Fuzzy (name and state)
- Nonprofit: RADY CHILDRENS HOSPITAL SAN DIEGO Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2022 | General payment | 49 | $50,527 |
| 2022 | Research payment | 19 | $229,974 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Amgen Inc. | 1 | $148,244 | 2022 |
| Soleno Therapeutics, Inc. | 2 | $40,129 | 2022 |
| PFIZER INC. | 3 | $35,657 | 2022 |
| Travere Therapeutics, Inc. | 2 | $20,500 | 2022 |
| National Marrow Donor Program | 5 | $15,020 | 2022 |
| B. Braun Medical Inc. | 1 | $5,000 | 2022 |
| Boehringer Ingelheim Pharma GmbH & Co.KG | 1 | $4,399 | 2022 |
| Medical Device Business Services, Inc. | 1 | $2,568 | 2022 |
| Merge Healthcare Incorporated | 30 | $2,502 | 2022 |
| Cochlear Americas | 1 | $2,000 | 2022 |
| Stryker Corporation | 2 | $1,248 | 2022 |
| Advanced Bionics, LLC | 1 | $1,000 | 2022 |
| KLS-Martin L.P. | 3 | $800 | 2022 |
| Radius Health, Inc. | 2 | $525 | 2022 |
| Eli Lilly and Company | 1 | $365 | 2022 |
| Merck Sharp & Dohme LLC | 1 | $263 | 2022 |
| Incyte Corporation | 8 | $178 | 2022 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $36 | 2022 |
| KARL STORZ Endoscopy-America | 1 | $32 | 2022 |
| Medical Graphics Corporation | 1 | $30 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 19 | $229,974 |
| Charitable Contribution | 6 | $28,025 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 4 | $14,320 |
| Grant | 1 | $2,568 |
| Food and Beverage | 30 | $2,502 |
| Debt forgiveness | 5 | $2,048 |
| Space rental or facility fees (teaching hospital only) | 1 | $1,000 |
| Long term medical supply or device loan | 1 | $32 |
| Gift | 1 | $30 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | Soleno Therapeutics, Inc. | $29,729 | Research payment | Cash or cash equivalent | An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Controlled-Release Tablet in Patients with | 2022 | |
| 2022-12-31 | Soleno Therapeutics, Inc. | $10,400 | Research payment | Cash or cash equivalent | A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients w | 2022 | |
| 2022-12-31 | Stryker Corporation | $1,035 | Debt forgiveness | Cash or cash equivalent | 2022 | ||
| 2022-12-31 | Merck Sharp & Dohme LLC | $263 | Research payment | In-kind items and services | NOXAFIL Drug, INFECTIOUS DISEASE | Phase IB study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children with Ne | 2022 |
| 2022-12-31 | Stryker Corporation | $213 | Debt forgiveness | Cash or cash equivalent | 2022 | ||
| 2022-12-30 | KARL STORZ Endoscopy-America | $32 | Long term medical supply or device loan | In-kind items and services | 2022 | ||
| 2022-11-30 | Radius Health, Inc. | $298 | Charitable Contribution | In-kind items and services | 2022 | ||
| 2022-11-30 | Radius Health, Inc. | $226 | Charitable Contribution | In-kind items and services | 2022 | ||
| 2022-11-27 | Merge Healthcare Incorporated | $263 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-11-27 | Merge Healthcare Incorporated | $263 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-11-27 | Merge Healthcare Incorporated | $263 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-11-27 | Merge Healthcare Incorporated | $263 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-11-27 | Merge Healthcare Incorporated | $263 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-11-27 | Merge Healthcare Incorporated | $33 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-11-27 | Merge Healthcare Incorporated | $33 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-11-27 | Merge Healthcare Incorporated | $33 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-11-27 | Merge Healthcare Incorporated | $33 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-11-27 | Merge Healthcare Incorporated | $33 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-11-07 | Travere Therapeutics, Inc. | $10,500 | Charitable Contribution | Cash or cash equivalent | 2022 | ||
| 2022-10-21 | National Marrow Donor Program | $5,350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-09-30 | PFIZER INC. | $4,800 | Research payment | Cash or cash equivalent | PREVNAR 13 Biological, VACCINES | THE UNITED STATES PEDIATRIC MULTICENTER PNEUMOCOCCAL SURVEILLANCE | 2022 |
| 2022-09-23 | B. Braun Medical Inc. | $5,000 | Charitable Contribution | Cash or cash equivalent | 2022 | ||
| 2022-08-16 | Cochlear Americas | $2,000 | Charitable Contribution | Cash or cash equivalent | Cochlear Device, Implantable hearing solution | 2022 | |
| 2022-08-05 | National Marrow Donor Program | $3,290 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-08-01 | Medical Device Business Services, Inc. | $2,568 | Grant | Cash or cash equivalent | 2022 | ||
| 2022-07-15 | National Marrow Donor Program | $700 | Research payment | Cash or cash equivalent | Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors | 2022 | |
| 2022-06-20 | PFIZER INC. | $15,428 | Research payment | In-kind items and services | A PHASE 2A 2PART OPENLABEL NONRANDOMIZED MULTICENTER SINGLE AND MULTIPLE DOSE TRIAL TO EVALUATE PHARMACOKINETICS SAFETY | 2022 | |
| 2022-06-13 | Travere Therapeutics, Inc. | $10,000 | Charitable Contribution | Cash or cash equivalent | 2022 | ||
| 2022-05-20 | KLS-Martin L.P. | $378 | Debt forgiveness | Cash or cash equivalent | 2022 | ||
| 2022-05-20 | KLS-Martin L.P. | $49 | Debt forgiveness | Cash or cash equivalent | 2022 | ||
| 2022-05-18 | Advanced Bionics, LLC | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | HIRES ULTRA CI HIFOCUS MS ELECTRODE Device, OTOLARYNGOLOGY | 2022 | |
| 2022-05-12 | KLS-Martin L.P. | $372 | Debt forgiveness | Cash or cash equivalent | 2022 | ||
| 2022-04-29 | National Marrow Donor Program | $2,310 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-04-07 | Merge Healthcare Incorporated | $74 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-04-07 | Merge Healthcare Incorporated | $74 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-04-07 | Merge Healthcare Incorporated | $74 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-04-07 | Merge Healthcare Incorporated | $74 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-04-07 | Merge Healthcare Incorporated | $74 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-03-18 | Eli Lilly and Company | $365 | Research payment | In-kind items and services | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY WITH AN OPEN-LABEL EXTENSION ASSESSING THE EFFICACY, SAFET | 2022 | |
| 2022-02-25 | Merge Healthcare Incorporated | $58 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-25 | Merge Healthcare Incorporated | $58 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-25 | Merge Healthcare Incorporated | $58 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-25 | Merge Healthcare Incorporated | $58 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-25 | Merge Healthcare Incorporated | $58 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-23 | Merge Healthcare Incorporated | $22 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-23 | Merge Healthcare Incorporated | $22 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-23 | Merge Healthcare Incorporated | $22 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-23 | Merge Healthcare Incorporated | $4 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-23 | Merge Healthcare Incorporated | $4 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-22 | Merge Healthcare Incorporated | $55 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-22 | Merge Healthcare Incorporated | $55 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-22 | Merge Healthcare Incorporated | $55 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-22 | Merge Healthcare Incorporated | $55 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-22 | Merge Healthcare Incorporated | $55 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2022 | |
| 2022-02-08 | Incyte Corporation | $69 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2022 | |
| 2022-02-08 | Incyte Corporation | $37 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2022 | |
| 2022-02-08 | Incyte Corporation | $24 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2022 | |
| 2022-02-08 | Incyte Corporation | $21 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2022 | |
| 2022-02-08 | Incyte Corporation | $12 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2022 | |
| 2022-02-08 | Incyte Corporation | $10 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2022 | |
| 2022-02-08 | Incyte Corporation | $3 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2022 | |
| 2022-02-08 | Incyte Corporation | $0 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2022 | |
| 2022-01-28 | National Marrow Donor Program | $3,370 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-01-26 | Boehringer Ingelheim Pharma GmbH & Co.KG | $4,399 | Research payment | In-kind items and services | TRADJENTA Drug, DIABETES | 52 wks Eff. & Saf. Ph III in Paediatrics | 2022 |
| 2022-01-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $36 | Research payment | In-kind items and services | TRADJENTA Drug, DIABETES | 52 wks Eff. & Saf. Ph III in Paediatrics | 2022 |
| 2022-01-19 | Amgen Inc. | $148,244 | Research payment | In-kind items and services | Blincyto Biological, Oncology | TOTAL THERAPY STUDY XVII (TOTXVII) FOR NEWLY DIAGNOSED PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOM | 2022 |
| 2022-01-07 | PFIZER INC. | $15,428 | Research payment | In-kind items and services | A PHASE 2A 2PART OPENLABEL NONRANDOMIZED MULTICENTER SINGLE AND MULTIPLE DOSE TRIAL TO EVALUATE PHARMACOKINETICS SAFETY | 2022 | |
| 2022-01-03 | Medical Graphics Corporation | $30 | Gift | In-kind items and services | 2022 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In San Diego, CA, county San Diego County, CA, state California; placed by its city name.
| Measure | Place (city or town) San Diego, CA | County San Diego County, CA | State California |
|---|---|---|---|
| Population B01003 | 1,389,526 | 3,288,774 | 39,287,377 |
| Population, 2020 census P1 | 1,386,932 | 3,298,634 | 39,538,223 |
| Median age B01002 | 36.2 | 37.3 | 37.9 |
| Under 18 B01001 | 18.4% | 20.9% | 22.0% |
| 65 and over B01001 | 14.6% | 15.4% | 15.7% |
| Households B11001 | 530,412 | 1,171,278 | 13,548,091 |
| Foreign born B05002 | 25.1% | 22.8% | 27.0% |
| Median household income B19013 | $108,077 | $106,268 | $99,122 |
| Median family income B19113 | $128,006 | $122,377 | $113,346 |
| Per capita income B19301 | $57,083 | $51,976 | $49,513 |
| Poverty rate B17001 | 11.0% | 10.3% | 12.0% |
| Unemployment rate B23025 | 6.0% | 6.1% | 6.6% |
| Civilian labor force B23025 | 755,893 | 1,689,384 | 20,068,466 |
| Mean commute (minutes) B08013 | 23.5 | 25.5 | 28.7 |
| Bachelor's degree or higher B15003 | 51.0% | 43.2% | 37.1% |
| Housing units B25001 | 568,668 | 1,250,641 | 14,644,735 |
| Owner-occupied B25003 | 47.3% | 54.6% | 55.9% |
| Renters B25003 | 52.7% | 45.4% | 44.1% |
| Median home value B25077 | $906,700 | $854,700 | $734,700 |
| Median gross rent B25064 | $2,313 | $2,246 | $2,036 |
| White, not Hispanic B03002 | 40.9% | 42.4% | 33.8% |
| Black B03002 | 5.3% | 4.4% | 5.2% |
| Hispanic or Latino B03002 | 29.8% | 34.6% | 40.2% |
| Asian B03002 | 17.3% | 12.1% | 15.3% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in San Diego, CA.
Comments